By Ankika Biswas and Shashwat Chauhan (Reuters) -European shares closed off their day's highs on Wednesday on growing evidences of slowing economic activity in the continent,...
By Amruta Khandekar, Matteo Allievi and Bansari Mayur Kamdar (Reuters) - European shares climbed on Wednesday after robust U.S. data overnight soothed concerns about a steep...
By Vlad Schepkov Investing.com -- Here is your weekly Pro Recap preview of key biotech and FDA catalysts to look out for in the next week: PDUFA reviews for Eyenovia and Protalix,...
By Senad Karaahmetovioc Biogen (NASDAQ:BIIB) shares are trading more than 5% higher in pre-market Monday after rival Roche (OTC:RHHBY) presented disappointing results for its...
By Liz Moyer Investing.com -- Stocks were mixed on Monday as investors awaited earnings reports from the biggest U.S. retailers this week. Here are the midday movers for Nov....
By Liz Moyer Investing.com -- U.S. stocks were mostly lower in early trading on Monday ahead of a week of earnings from major retailers, including Walmart (NYSE:WMT) and Target...
By Scott Kanowsky Investing.com -- Roche Holding AG Participation (SIX:ROG) says two long-awaited late-stage studies showed that its Alzheimer's disease treatment failed to stem a...
it will go up: the chart formed an "bulllish doji star"
1
This Is one and only real competitor in covid test from POLAND
http://scopefluidics.com/scope-fluidics-is-developing-an-ultra-fast-covid-19-panel-for-its-pcrone-rapid-molecular-diagnostic-system/
0
Roche just announced as the test pushed through for Covid 19 Tessting. Up Up Up!
2
Jan 26, 2020 Sun $41.20 its GENE is dazzling as always focusing on breakthrough sciences